GlucoTrack, Inc. GCTK NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • IL • USD

SharesGrow Score

63/100

2/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

GlucoTrack, Inc. (GCTK) has a negative trailing P/E of 0.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -3,309.64%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E 0.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -3,309.64%).
Trailing Earnings Yield -3,309.64% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 58/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

63/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

28/100

→ Income

✓

GROWTH

100/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — GCTK

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.21

P/S Ratio0.00

EV/EBITDA0.4

Per Share Data

EPS (TTM)$-21.56

Book Value / Share$3.14

Revenue / Share$0.00

FCF / Share$-17.05

Yields & Fair Value

Earnings Yield-3,309.64%

Dividend Yield0.00%

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2016	0.0	0.00	0.00	0.00	-
2017	0.0	0.00	0.00	0.00	-
2018	0.0	0.00	0.00	0.00	-
2019	-1,584.0	0.00	-3,944.19	26,775.00	-
2020	-1,540.6	39.11	462.42	0.00	-
2021	-947.4	-20.07	747.45	0.00	-
2022	-293.8	-33.04	1,059.22	0.00	-
2023	-40.9	-1.22	90.79	0.00	-
2024	-7.4	0.03	-12.81	0.00	-
2025	-0.2	0.00	1.23	0.00	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$0.00	$611.69K	$-5.41M	-884.4%
2017	$0.00	$589.46K	$-10.33M	-1752.2%
2018	$0.00	$43.49K	$-6.72M	-15442%
2019	$-29.50	$208.76K	$-3.52M	-1684.3%
2020	$-17.88	$0.00	$-2.6M	-
2021	$-26.32	$0.00	$-4.1M	-
2022	$-28.66	$0.00	$-4.44M	-
2023	$-38.30	$0.00	$-7.1M	-
2024	$60.76	$0.00	$22.6M	-
2025	$-21.56	$0.00	$-19.39M	-